Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Ovarian Neoplasms 23Breast Neoplasms 12Prostatic Neoplasms 11Triple Negative Breast Neoplasms 7Fallopian Tube Neoplasms 7Stomach Neoplasms 5Neoplasm Metastasis 5Sarcoma 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Metastatic Castration-resistant Prostate Cancer 4Fanconi Anemia, Complementation Group D1 4Small Cell Lung Carcinoma 3Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Pancreatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioma 2Ependymoma 2Endometrial Neoplasms 2

Interventions

Tobacco Use Cessation Devices 2zileuton 1olaparib 1Vitamin B 12 1Varenicline 1Radiotherapy 1Patient Navigation 1Nicotine Replacement Therapy 1Folic Acid 1Erlotinib Hydrochloride 1Cycloserine 1Cetuximab 1Celecoxib 1Budesonide 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Smoking × olaparib × Clear all
NCT01758731 2019-09-23

Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History

University of Colorado, Denver

Phase 1 Completed
17 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡